Long-term observational safety study to evaluate the nature and incidence of adverse effects of deferiprone treatment in patients with beta-thalassaemia major aged from 1 month to less than 18 years. (DEEP-3) First published 11/04/2013 Last updated 13/01/2016 EU PAS number:EUPAS3803 Study Ongoing